Marshall Wace
HZNP

Marshall Wace’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Marshall Wace’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-674,698
Closed -$78.1M – 2779
2023
Q3 		$78.1M Buy
674,698
+52,484
+8% +$5.64M 0.16% 124
2023
Q2 		$64M Buy
622,214
+221,893
+55% +$23.4M 0.13% 172
2023
Q1 		$43.7M Sell
400,321
-66,970
-14% -$7.4M 0.09% 246
2022
Q4 		$53.2M Sell
467,291
-2,039,038
-81% -$169M 0.12% 187
2022
Q3 		$155M Buy
2,506,329
+2,347,834
+1,481% +$164M 0.34% 46
2022
Q2 		$12.6M Sell
158,495
-499,611
-76% -$47.3M 0.03% 708
2022
Q1 		$69.2M Sell
658,106
-998,573
-60% -$97.3M 0.13% 159
2021
Q4 		$179M Buy
1,656,679
+1,614,010
+3,783% +$176M 0.33% 43
2021
Q3 		$4.67M Buy
+42,669
New +$4.43M 0.02% 973
2021
Q2 		– Sell
-3,097
Closed -$285K – 3527
2021
Q1 		$285K Sell
3,097
-72,522
-96% -$6.12M ﹤0.01% 2144
2020
Q4 		$5.53M Buy
75,619
+65,684
+661% +$4.88M 0.03% 534
2020
Q3 		$772K Sell
9,935
-104,307
-91% -$7.18M ﹤0.01% 1110
2020
Q2 		$6.35M Buy
+114,242
New +$4.89M 0.04% 406
2019
Q2 		– Sell
-40,895
Closed -$1.08M – 2090
2019
Q1 		$1.08M Buy
+40,895
New +$969K 0.01% 904
2016
Q4 		– Sell
-20,886
Closed -$379K – 1203
2016
Q3 		$379K Buy
+20,886
New +$408K ﹤0.01% 832
2015
Q4 		– Sell
-32,809
Closed -$650K – 1200
2015
Q3 		$650K Sell
32,809
-121,974
-79% -$3.85M 0.01% 697
2015
Q2 		$5.38M Sell
154,783
-268,660
-63% -$8.2M 0.07% 292
2015
Q1 		$11M Buy
423,443
+247,132
+140% +$4.53M 0.14% 187
2014
Q4 		$2.27M Sell
176,311
-28,037
-14% -$351K 0.03% 436
2014
Q3 		$2.51M Sell
204,348
-10,812
-5% -$126K 0.04% 405
2014
Q2 		$3.4M Sell
215,160
-296,063
-58% -$4.23M 0.05% 317
2014
Q1 		$7.73M Buy
+511,223
New +$5.77M 0.14% 183

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Marshall Wace's HZNP Position: Q4 2023 in Review

Marshall Wace sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 674,698 shares — an estimated $78.1M sold.

Marshall Wace first reported a position in HZNP in Q1 2014 and held it in 22 quarters. The position peaked at $179M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Marshall Wace reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Marshall Wace sold 674,698 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $78.1M.
  • Marshall Wace first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 22 quarters.
  • Marshall Wace's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $179M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.